Yu-Chieh Tsai

Yu-Chieh Tsai
Education: Sep.1991 - June 1998 School of Medicine, National Taiwan University (MD) Sep.2006 - Aug 2015 Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine (PhD) Post-graduate Training: July 2000 - June 2003 Resident, Internal Medicine, National Taiwan University Hospital July 2003 - June 2005 Fellow and chief resident, Department of Oncology, National Taiwan University Hospital Jan.2008 - Dec. 2009 Research Fellow, Department of Pathology, School of Medicine and Dentistry, University of Rochester Board and Certification: 1998 M.D. License Registration 2003 Board of Internal Medicine 2005 Board of Medical Oncology

16th August 2025

Time Session
13:30
15:00
Recent Advancements in Muscle-Invasive Urothelial Carcinoma
  • Cheng-Kuang YangTaiwan Speaker Robotic Radical Prostatectomy: Trying to Fit the Right Surgery to the Right PatientDefinitive treatment for localized prostate cancer included radical prostatectomy and radiation. Successful criteria of radical prostatectomy have to meet oncology control, not persistent PSA after surgery without salvage therapy. MRI imaging stage and PSA density are predictors for short‐term BCR after prostatectomy. NCCN‐defined high‐risk patients with a high initial PSA 28 density, imaging stage (T3aN0M0 and T3bN0M0), and 29 pathologic stage (any N1) had a higher risk of BCR when 30 compared with other patients with undetectable PSA, while 31 those with pathologic stage (T3bN0M0 or any N1) displayed 32 a higher risk of postoperatively detectable PSA. These find‐ 33 ings may help urologists to identify patients for whom active 34 therapeutic protocols are necessary.
  • Cheng-Kuang YangTaiwan Speaker Robotic Radical Prostatectomy: Trying to Fit the Right Surgery to the Right PatientDefinitive treatment for localized prostate cancer included radical prostatectomy and radiation. Successful criteria of radical prostatectomy have to meet oncology control, not persistent PSA after surgery without salvage therapy. MRI imaging stage and PSA density are predictors for short‐term BCR after prostatectomy. NCCN‐defined high‐risk patients with a high initial PSA 28 density, imaging stage (T3aN0M0 and T3bN0M0), and 29 pathologic stage (any N1) had a higher risk of BCR when 30 compared with other patients with undetectable PSA, while 31 those with pathologic stage (T3bN0M0 or any N1) displayed 32 a higher risk of postoperatively detectable PSA. These find‐ 33 ings may help urologists to identify patients for whom active 34 therapeutic protocols are necessary.
TICC - 1F 101C